GB0031390D0 - Methods - Google Patents

Methods

Info

Publication number
GB0031390D0
GB0031390D0 GBGB0031390.8A GB0031390A GB0031390D0 GB 0031390 D0 GB0031390 D0 GB 0031390D0 GB 0031390 A GB0031390 A GB 0031390A GB 0031390 D0 GB0031390 D0 GB 0031390D0
Authority
GB
United Kingdom
Prior art keywords
methods
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB0031390.8A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Ip2ipo Innovations Ltd
Original Assignee
Imperial College Innovations Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Imperial College Innovations Ltd filed Critical Imperial College Innovations Ltd
Priority to GBGB0031390.8A priority Critical patent/GB0031390D0/en
Publication of GB0031390D0 publication Critical patent/GB0031390D0/en
Priority to PCT/GB2001/005722 priority patent/WO2002050263A2/fr
Priority to AU2002216243A priority patent/AU2002216243A1/en
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/28—Bone marrow; Haematopoietic stem cells; Mesenchymal stem cells of any origin, e.g. adipose-derived stem cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K2035/124—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells the cells being hematopoietic, bone marrow derived or blood cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Cell Biology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Zoology (AREA)
  • Medicinal Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Virology (AREA)
  • Hematology (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
GBGB0031390.8A 2000-12-21 2000-12-21 Methods Ceased GB0031390D0 (en)

Priority Applications (3)

Application Number Priority Date Filing Date Title
GBGB0031390.8A GB0031390D0 (en) 2000-12-21 2000-12-21 Methods
PCT/GB2001/005722 WO2002050263A2 (fr) 2000-12-21 2001-12-21 Procedes
AU2002216243A AU2002216243A1 (en) 2000-12-21 2001-12-21 Methods_for treating tissue damage by bone-marrow derived stem cells

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB0031390.8A GB0031390D0 (en) 2000-12-21 2000-12-21 Methods

Publications (1)

Publication Number Publication Date
GB0031390D0 true GB0031390D0 (en) 2001-02-07

Family

ID=9905694

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB0031390.8A Ceased GB0031390D0 (en) 2000-12-21 2000-12-21 Methods

Country Status (3)

Country Link
AU (1) AU2002216243A1 (fr)
GB (1) GB0031390D0 (fr)
WO (1) WO2002050263A2 (fr)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1613742A2 (fr) 2003-04-08 2006-01-11 YEDA RESEARCH AND DEVELOPMENT Co. LTD. Cellules souches presentant une sensibilite accrue a un agent chimio-attractif, methodes de production et d'utilisation associees
JPWO2004091661A1 (ja) * 2003-04-15 2006-07-06 中外製薬株式会社 糖尿病治療剤
US10786532B2 (en) 2012-10-02 2020-09-29 Versiti Blood Research Institute Foundation, Inc. Method of providing cellular therapy using modified natural killer cells or T lymphocytes

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0938904A1 (fr) * 1998-02-09 1999-09-01 Leuven Research & Development vzw Transduction des cellules mammifères pour utilisation dans la thérapie génique
AU4214799A (en) * 1998-05-28 1999-12-13 St. Jude Children's Research Hospital Expansion of hematopoietic stem cells transduced with mdr-1 and methods of use thereof
CA2334217C (fr) * 1998-06-08 2007-04-17 Acgt Medico, Inc. Detection d'adn, d'arn et de proteines

Also Published As

Publication number Publication date
WO2002050263A3 (fr) 2003-02-06
AU2002216243A1 (en) 2002-07-01
WO2002050263A2 (fr) 2002-06-27

Similar Documents

Publication Publication Date Title
AU3391801A (en) Pyridinylimidazoles
AU8274301A (en) Electro-powder
AU6803901A (en) Bis-arylsulfones
DE50102859D1 (en) Hochfliessfähige propylenblockcopolymerisate
AU9385201A (en) Sulfonylguanidine
DE50008626D1 (en) Substituierte aminomethyl-phenyl-cyclohexanderivate
AU6619001A (en) Liquid-pourers
DE50008447D1 (en) Aminomethyl-phenyl-cyclohexanonderivate
GB0015923D0 (en) Methods
AU9187601A (en) Triazolo-epothilones
AU4686401A (en) Hypotensors
DE50100877D1 (en) Thermoverformbares verbundmaterial
DE50006446D1 (en) Otoplastik
AU4831301A (en) Gm-negative ehv-mutants
GB0026094D0 (en) Methods
GB0031744D0 (en) Methods
AU8756801A (en) Thienopyrrolidinones
GB0001005D0 (en) Methods
DE50103809D1 (en) Hydrocephalusventil
DE50013705D1 (en) Otoplastik
DE50003404D1 (en) Multi-master-bus-system
GB0031390D0 (en) Methods
GB0102454D0 (en) Methods
GB0021859D0 (en) Methods
GB0024510D0 (en) Methods

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)